Invesaro

Stocks Health care EHC

NYSE · Health care

Encompass Health Corp (EHC)

Encompass Health Corp brought in $6.3B of revenue over the twelve months to September 30, 2026, up 9.4% from a year earlier. Net income was $644.4M, a net margin of 10.2%. Operating cash flow minus capital spending left $439.2M of free cash flow in fiscal 2025. At September 30, 2026 it held $76.2M in cash against $2.6B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 3, 2026.

Free, no password. An email when EHC files with the SEC.

Price
$141.15
+2.63% on the day · November 9, 2026
52-week range $92.77 to $143.36
Market cap
$13.9B
Revenue (last 12 months)
$6.3B
+9.4% year on year
Net margin
10.2%
P/E
25.5
on FY2025 diluted EPS

Key facts about Encompass Health Corp

Net worth
Encompass Health Corp has a market value (market cap) of $13.9B at the latest share price, and shareholders' equity of $2.7B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $5.9B (+10.5% year on year), with net income of $566.2M. Over the 12 months to September 30, 2026: revenue $6.3B, net income $644.4M.
Cash flow
In fiscal 2025 operations brought in $1.2B of cash; after $736.4M of capital spending, free cash flow was $439.2M.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 3, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report
Encompass Health Corp's next report is expected around February 4, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Dividend
Encompass Health Corp declared dividends of $0.72 per share in fiscal 2025, a yield of 0.51% at the current price.

What Encompass Health Corp does

Encompass Health Corp is registered with the SEC under industry code SIC 8060 (Services-Hospitals). Its shares trade on NYSE under the ticker EHC.

Revenue and profit by year

Revenue
FY18: $4.3B $4.3B FY18FY19: $4.6B $4.6B FY19FY20: $3.6B $3.6B FY20FY21: $4B $4B FY21FY22: $4.3B $4.3B FY22FY23: $4.8B $4.8B FY23FY24: $5.4B $5.4B FY24FY25: $5.9B $5.9B FY25
Net income
FY18: $292.3M $292.3M FY18FY19: $358.7M $358.7M FY19FY20: $284.2M $284.2M FY20FY21: $412.2M $412.2M FY21FY22: $271M $271M FY22FY23: $352M $352M FY23FY24: $455.7M $455.7M FY24FY25: $566.2M $566.2M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$5.9Bn/a$566.2M$5.54$439.2M
2024$5.4Bn/a$455.7M$4.46$360.3M
2023$4.8Bn/a$352M$3.47$267.7M
2022$4.3B$539.5M$271M$2.70$141M
2021$4B$559.6M$412.2M$4.11$191.2M
2020$3.6B$563.9M$284.2M$2.85$311.9M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around February 4, 2027.

Estimated from its filing rhythm: 52 weeks after its report of February 5, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where EHC ranks in Health care

Revenue$5.9B
#59 of 751 in Health care · Top 8%
Revenue growth+10.5%
#276 of 532 in Health care · Bottom 48%
Net margin9.5%
#114 of 544 in Health care · Top 21%
Free cash flow margin7.4%
#154 of 490 in Health care · Top 31%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

Encompass Health Corp declared $0.72 per share in fiscal 2025. At the current price that is a yield of 0.51%. It paid out $71.1M in cash dividends, 13% of its net income.

Fiscal yearPer sharePaid outOf profit
2025$0.72$71.1M13%
2024$0.64$62.8M14%
2023$0.60$60.4M17%
2022$0.86$99M37%
2021$1.12$112.2M27%
2020$1.12$111.8M39%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Encompass Health Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 6, 2026
  2. November 3, 2026
    Quarterly report 10-Q · period to September 30, 2026Revenue rose 8.9% to $1.6B versus the same quarter last year; diluted EPS $1.50 versus $1.24.
  3. October 28, 2026
  4. August 19, 2026
  5. August 14, 2026
  6. August 13, 2026
  7. August 7, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 9.6% to $1.6B versus the same quarter last year; diluted EPS $1.54 versus $1.39.
  8. August 5, 2026
  9. July 31, 2026
  10. June 1, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 19, 2026. Insider transactions on SEC

What is EHC worth? A DCF from its reported cash flow

Insider trades

What the people running Encompass Health Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $1.2M worth of shares in the last 90 days and bought none on the open market.

Bought (open market)
$0
last 90 days
Sold
$1.2M
last 90 days
Net sold
10,069
$1.2M
DateInsiderWhatSharesPriceValueFiling
October 19, 2026 Reidy Christopher RDirector Received as pay 284 $126.89 $36K Form 4
October 19, 2026 Christie Edward M IIIDirector Received as pay 221 $126.63 $28K Form 4
October 15, 2026 Katz Leslye GDirector Received as pay 81 - - Form 4
October 15, 2026 O'Connor Kevin J.Director Received as pay 18 - - Form 4
October 15, 2026 Hayes Cain ADirector Received as pay 4 - - Form 4
October 15, 2026 Reidy Christopher RDirector Received as pay 20 - - Form 4
October 15, 2026 Christie Edward M IIIDirector Received as pay 11 - - Form 4
October 15, 2026 Herman Joan EDirector Received as pay 81 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns EHC

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Vanguard Capital Management13G, passive 5.26% 5,233,622 April 29, 2026
T. Rowe Price Associates, Inc.13G, passive 5.1% 5,056,225 August 14, 2026

Latest filings below 5%: Vanguard Portfolio Management 4.97% (July 31, 2026); The Vanguard Group 0% (March 26, 2026); Wellington Management Group LLP 4% (February 10, 2025); William Blair Investment Management, LLC 3.3% (November 14, 2024).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 597 managers reported a position.

HolderSharesValueChange on quarter
BlackRock, Inc.10,484,385$1.06B-284,328
Vanguard Portfolio Management LLC4,924,664$497.8M-34,881
Vanguard Capital Management LLC4,475,896$452.4M+9,659
Wellington Management Group Llp3,278,739$331.4M-570,116
State Street Corp3,185,798$322M+40,824
Citadel Advisors LLC2,563,104$259.1M+2,051,217
Fuller & Thaler Asset Management, Inc.2,460,657$248.7M+230,678
Alliancebernstein L.P.2,471,751$239.1M-149,494
Two Sigma Investments, LP2,267,668$229.2M+45,567
Geode Capital Management, LLC1,890,743$191.2M-7,924
Dimensional Fund Advisors LP1,743,028$176.2M+68,244
Goldman Sachs Group Inc1,550,797$156.8M-254,924
Invesco Ltd.1,161,108$117.4M-2,224,997
Arrowstreet Capital, Limited Partnership1,156,930$116.9M-25,644
Norges Bank1,154,864$116.7Mnew
William Blair Investment Management, LLC1,151,085$116.4M+347,934
Morgan Stanley1,146,873$115.9M+249,891
Jpmorgan Chase & Co1,133,561$114.8M-97,910
Raymond James Financial Inc1,064,233$107.6M-2,773
American Century Companies Inc1,050,470$106.2M+298,417

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

16 insiders reported holding 792,650 shares in total, about $111.9M at the last price.

HolderSharesAs of
Tarr Mark JPresident & CEO, Director 267,814 August 10, 2026
Fay EdmundSr. Vice Pres. and Treasurer 86,325 March 9, 2026
Darby John PatrickEVP, Gen Counsel & Secretary 75,041 August 31, 2026
Price Andrew LChief Accounting Officer 69,483 August 31, 2026
Coltharp Douglas EEVP & Chief Financial Officer 50,508 August 10, 2026
Katz Leslye GDirector 49,724 October 15, 2026
Herman Joan EDirector 49,724 October 15, 2026
Tuer Patrick WilliamEVP, Chief Operating Officer 24,755 May 11, 2026
Schlichting Nancy MDirector 23,010 October 15, 2026
Carmichael Greg DDirector 20,377 October 15, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about EHC

What does Encompass Health Corp do?

Encompass Health Corp is a company in the Health care sector, listed on NYSE as EHC. Its shares trade on NYSE under the ticker EHC.

What is Encompass Health Corp's net worth?

Encompass Health Corp has a market value (market cap) of $13.9B at the latest share price, and shareholders' equity of $2.7B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Encompass Health Corp profitable?

Yes. Over the twelve months to September 30, 2026 it reported net income of $644.4M on revenue of $6.3B, a net margin of 10.2%.

How much revenue does Encompass Health Corp make?

Over the twelve months to September 30, 2026 Encompass Health Corp reported revenue of $6.3B. That is 9.4% more than a year earlier.

When did Encompass Health Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 3, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the investor disclosure from November 6, 2026.

When is Encompass Health Corp's next earnings report?

Encompass Health Corp's next report is expected around February 4, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Does Encompass Health Corp pay a dividend?

Yes. Encompass Health Corp declared dividends of $0.72 per share in fiscal 2025, a yield of 0.51% at the current price.

Similar companies

Compare EHC with

Compare EHC with any company

Follow EHC

Get an email when Encompass Health Corp files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when EHC files with the SEC.

Where the numbers come from

Financial figures are the values Encompass Health Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.